FEATURED POST

In the crosshairs of conscience: John Kitzhaber's death penalty reckoning

Image
To cope with his dread, John Kitzhaber opened his leather-bound journal and began to write.
It was a little past 9 on the morning of Nov. 22, 2011. Gary Haugen had dropped his appeals. A Marion County judge had signed the murderer's death warrant, leaving Kitzhaber, a former emergency room doctor, to decide Haugen's fate. The 49-year-old would soon die by lethal injection if the governor didn't intervene.
Kitzhaber was exhausted, having been unable to sleep the night before, but he needed to call the families of Haugen's victims.
"I know my decision will delay the closure they need and deserve," he wrote.
The son of University of Oregon English professors, Kitzhaber began writing each day in his journal in the early 1970s. The practice helped him organize his thoughts and, on that particular morning, gather his courage.
Kitzhaber first dialed the widow of David Polin, an inmate Haugen beat and stabbed to death in 2003 while already serving a life sentence fo…

Dutch pharma firm reprimanded for drug used in U.S. executions

The Dutch branch of the Organization for Economic Cooperation and Development (OECD) reprimanded pharmaceutical company Mylan for doing to little to prevent their drugs being used in executions in the United States, the Volkskrant reports.

The OECD reprimanded Mylan at the insistence of death penalty lawyer Bart Staperd.

The pharmaceutical company now has to update its sales policy and make sure that their products are not used in executions. 

Mylan is originally an American company, but is established in the Netherlands for tax reasons. It therefore has to comply with Dutch human rights laws and provisions.

The drug involved is muscle relaxant rocuronium bromide. In the United States it is used as part of the cocktail given to death penalty prisoners at their execution.

Mylan initially defended itself by claiming that they do not always have control over the distribution of the drug. They sell rocuronium bromide wholesale to American hospitals, to be used for anesthesia in medical treatments. It is not directly supplied to prisons.

The OECD does not find that excuse acceptable, and instructed Mylan to better monitor the trade of the drug, even after they sold it. The company now promised to put more effort into monitoring where the drug ends up.

Source: nltimes.nl, April 12, 2016

- Report an error, an omission: deathpenaltynews@gmail.com - Follow us on Facebook and Twitter

Most Viewed (Last 7 Days)

Convicted killer from infamous “Texas 7” prison escape gets execution date

Malaysian court sentences Australian grandmother to death by hanging

Post Mortem – the execution of Edward Earl Johnson

Ohio: Lawyers seek review of death sentence for 23-year-old Clayton man

Nebraska seeks July 10 date for state's 1st execution since 1997

Texas man on death row for decapitating 3 kids loses appeal

Amnesty International Once Again Highlights Shocking Justice System in Iran

Maria Exposto: Can she avoid execution?

In the crosshairs of conscience: John Kitzhaber's death penalty reckoning

Ohio man with execution set for July 18 blames killing on ‘homosexual panic’